MUC4 inhibition has been reported to suppress cell growth and metastasis in pancreatic tumor cells [61] and its potential as therapeutic target for pancreatic ductal adenocarcinomas has been reviewed in [62]. The gene discussed is MUC4; the disease is pancreatic ductal adenocarcinoma.